These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 2883012)

  • 21. A study of the mechanism of MDMA ('ecstasy')-induced neurotoxicity of 5-HT neurones using chlormethiazole, dizocilpine and other protective compounds.
    Colado MI; Green AR
    Br J Pharmacol; 1994 Jan; 111(1):131-6. PubMed ID: 7516800
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral administration of 3,4-methylenedioxymethamphetamine (MDMA) produces selective serotonergic depletion in the nonhuman primate.
    Ali SF; Newport GD; Scallet AC; Binienda Z; Ferguson SA; Bailey JR; Paule MG; Slikker W
    Neurotoxicol Teratol; 1993; 15(2):91-6. PubMed ID: 7685472
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of flunarizine and nimodipine on the decrease in tryptophan hydroxylase activity induced by methamphetamine and 3,4-methylenedioxymethamphetamine.
    Johnson M; Mitros K; Stone DM; Zobrist R; Hanson GR; Gibb JW
    J Pharmacol Exp Ther; 1992 May; 261(2):586-91. PubMed ID: 1374469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Direct central effects of acute methylenedioxymethamphetamine on serotonergic neurons.
    Schmidt CJ; Taylor VL
    Eur J Pharmacol; 1988 Oct; 156(1):121-31. PubMed ID: 2463176
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MDMA: historical perspectives.
    Gibb JW; Johnson M; Stone D; Hanson GR
    Ann N Y Acad Sci; 1990; 600():601-11; discussion 611-2. PubMed ID: 1979213
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of 3,4-dihydroxymethamphetamine and 2,4,5-trihydroxymethamphetamine, two metabolites of 3,4-methylenedioxymethamphetamine, on central serotonergic and dopaminergic systems.
    Johnson M; Elayan I; Hanson GR; Foltz RL; Gibb JW; Lim HK
    J Pharmacol Exp Ther; 1992 May; 261(2):447-53. PubMed ID: 1349640
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prenatal 3,4-methylenedioxymethamphetamine (ecstasy) alters exploratory behavior, reduces monoamine metabolism, and increases forebrain tyrosine hydroxylase fiber density of juvenile rats.
    Koprich JB; Chen EY; Kanaan NM; Campbell NG; Kordower JH; Lipton JW
    Neurotoxicol Teratol; 2003; 25(5):509-17. PubMed ID: 12972064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reserpine does not prevent 3,4-methylenedioxymethamphetamine-induced neurotoxicity in the rat.
    Hekmatpanah CR; McKenna DJ; Peroutka SJ
    Neurosci Lett; 1989 Sep; 104(1-2):178-82. PubMed ID: 2573011
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regional distribution to recovery of 5-HT levels after administration of "atrophins" MDMA and D,L-fenfluramine. Stereospecificity and comparison with 5,7-dihydroxytryptamine.
    Lehmann J; DeSouza EB; Culp S; Zaczek R
    Ann N Y Acad Sci; 1992 May; 648():291-5. PubMed ID: 1379013
    [No Abstract]   [Full Text] [Related]  

  • 30. Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and related amphetamine derivatives on inhibition of uptake of [3H]monoamines into synaptosomes from different regions of rat brain.
    Steele TD; Nichols DE; Yim GK
    Biochem Pharmacol; 1987 Jul; 36(14):2297-303. PubMed ID: 2886126
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of acute N-ethyl-3,4-methylenedioxyamphetamine (MDE) action on the central serotonergic system.
    Johnson M; Hanson GR; Gibb JW
    Biochem Pharmacol; 1989 Dec; 38(23):4333-8. PubMed ID: 2480796
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of MK-801 on the decrease in tryptophan hydroxylase induced by methamphetamine and its methylenedioxy analog.
    Johnson M; Hanson GR; Gibb JW
    Eur J Pharmacol; 1989 Jun; 165(2-3):315-8. PubMed ID: 2570704
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurotoxic effects of the alpha-ethyl homologue of MDMA following subacute administration.
    Johnson MP; Nichols DE
    Pharmacol Biochem Behav; 1989 May; 33(1):105-8. PubMed ID: 2476831
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The hyperthermic and neurotoxic effects of 'Ecstasy' (MDMA) and 3,4 methylenedioxyamphetamine (MDA) in the Dark Agouti (DA) rat, a model of the CYP2D6 poor metabolizer phenotype.
    Colado MI; Williams JL; Green AR
    Br J Pharmacol; 1995 Aug; 115(7):1281-9. PubMed ID: 7582557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. (+/-)3,4-Methylenedioxymethamphetamine selectively damages central serotonergic neurons in nonhuman primates.
    Ricaurte GA; Forno LS; Wilson MA; DeLanney LE; Irwin I; Molliver ME; Langston JW
    JAMA; 1988 Jul; 260(1):51-5. PubMed ID: 2454332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain.
    Commins DL; Vosmer G; Virus RM; Woolverton WL; Schuster CR; Seiden LS
    J Pharmacol Exp Ther; 1987 Apr; 241(1):338-45. PubMed ID: 2883295
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 5-Hydroxyindoleacetic acid in cerebrospinal fluid reflects serotonergic damage induced by 3,4-methylenedioxymethamphetamine in CNS of non-human primates.
    Ricaurte GA; DeLanney LE; Wiener SG; Irwin I; Langston JW
    Brain Res; 1988 Dec; 474(2):359-63. PubMed ID: 2463059
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differences between rats and mice in MDMA (methylenedioxymethylamphetamine) neurotoxicity.
    Logan BJ; Laverty R; Sanderson WD; Yee YB
    Eur J Pharmacol; 1988 Aug; 152(3):227-34. PubMed ID: 2906000
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity.
    O'Hearn E; Battaglia G; De Souza EB; Kuhar MJ; Molliver ME
    J Neurosci; 1988 Aug; 8(8):2788-803. PubMed ID: 2457659
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 3,4-Methylenedioxyamphetamine (MDA) analogues exhibit differential effects on synaptosomal release of 3H-dopamine and 3H-5-hydroxytryptamine.
    McKenna DJ; Guan XM; Shulgin AT
    Pharmacol Biochem Behav; 1991 Mar; 38(3):505-12. PubMed ID: 1829838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.